Company intelligence
International Vaccine Institute (IVI)
We discover, develop, and deliver safe, effective, and affordable vaccines for global health.
About International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is an independent international organization originally established at the initiative of the United Nations Development Programme in 1997. Its mission is to discover, develop, and deliver safe, effective, and affordable vaccines—empowering vaccine equity, impact, and sustainability globally. IVI’s current portfolio includes vaccines in multiple stages of pre-clinical and clinical development targeting infectious diseases that significantly impact low- and middle-income countries, including cholera, typhoid fever, chikungunya, shigellosis, salmonellosis, schistosomiasis, hepatitis E, HPV- and group A strep-related diseases, and COVID-19. IVI developed the world’s first low-cost oral cholera vaccine and a new-generation typhoid conjugate vaccine, both pre-qualified by the World Health Organization (WHO). IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, an Africa Regional Office in Rwanda, a Country Office in Austria, and a Country and Project Office in Kenya. IVI additionally co-founded the Hong Kong Jockey Club Global Health Institute in Hong Kong and hosts Collaborating Centers in Bhutan, Burkina Faso, Ghana, Ethiopia, Nepal, and Madagascar. More than 40 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, Austria, and Thailand provide state funding. For more information, please visit https://www.ivi.int.
Verified activity
Signals from International Vaccine Institute (IVI)
14 published signals
Research & Knowledge
International Vaccine Institute (IVI) led the Enhancing Cholera Control in Mozambique (ECHO-M) project, which concluded after six years with lasting gains for cholera prevention and control.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) hosted the 2026 International Vaccinology Course in Seoul, Kigali, and Stockholm over five days.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) received the National Research Foundation of South Africa’s 2026 Lifetime Achievement Award for Professor Helen Rees
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) fellows from low- and middle-income countries shared their research during poster sessions in Seoul, Kigali, and Stockholm during the 2026 International Vaccinology Course.
Reported by International Vaccine Institute (IVI)
People
International Vaccine Institute (IVI) announced the 2026 IVI Vaccinology Fellows, supporting promising vaccine professionals from low- and middle-income countries to participate in the International Vaccinology Course.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) welcomed colleagues from The Biovac Institute, the South African Medical Research Council, and five clinical trial sites participating in an IVI-supported phase I/III oral cholera vaccine trial in South Africa.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) selected 11 Vaccinology Fellows and 13 scholars supported by the East African Community Regional Centre of Excellence for Vaccines, Immunization, and Health Supply Chain Management to attend the Kigali course.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) hosted the International Vaccinology Course in Kigali with the University of Rwanda, bringing together participants from 20 nationalities.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) attended the AVVCC26 conference in Australia, bringing partners together.
Reported by International Vaccine Institute (IVI)
People
International Vaccine Institute (IVI) welcomed 21 interns from around the world to its headquarters in Seoul this summer.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) hosted a Careers in Vaccinology panel in Seoul, Kigali, and Stockholm to reflect on career journeys and mentorship.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) hosted the 25th International Vaccinology Course at IVI Headquarters in Seoul with over 60 participants from Africa, Asia, Europe, South America, and beyond.
Reported by International Vaccine Institute (IVI)
Presence & Recognition
International Vaccine Institute (IVI) and Karolinska Institutet (KI) are hosting the Stockholm site of the 2026 International Vaccinology Course, led by IVI and part of KI’s doctoral education.
Reported by International Vaccine Institute (IVI)
Partnerships
International Vaccine Institute (IVI) and the Swedish medical university Karolinska Institutet (KI) have signed a memorandum of understanding to strengthen their existing cooperation in vaccine research and education.
Reported by International Vaccine Institute (IVI)